NASAL DECONGESTANT PE 10mg

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: NASAL DECONGESTANT PE 10mg
Generic name: PHENYLPHRINE HCL
Manufacturer: YYBA CORP
Product type: HUMAN OTC DRUG
SPL set ID: 05824fc4-ef3f-4ebb-b601-252f76ad60ef
SPL ID: 0e13a1f1-87bb-b26e-e063-6294a90a87f8
Version: 6
Effective date: 2024-01-03
Source export date: 2026-10-27
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/35717de05250cd386420cc8ede3b6010b48d18eea2af59afb0617fcabca634ec/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:00:25

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		NASAL DECONGESTANT PE 10mg	openfda.brand_name
generic name		PHENYLPHRINE HCL	openfda.generic_name
manufacturer name		YYBA CORP	openfda.manufacturer_name
ndc	package	73581-204-02	openfda.package_ndc
ndc	product	73581-204	openfda.product_ndc
ndc11	package	73581020402	derived:openfda.package_ndc
spl id		0e13a1f1-87bb-b26e-e063-6294a90a87f8	id
spl set id		05824fc4-ef3f-4ebb-b601-252f76ad60ef	set_id
unii		04JA59TNSJ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use if you are taking a prescription monoamine oxidase inhibitor (MA0l)(certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MA0l drug. If you do not know if your prescription drug contains an MA0l, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have heart disease diabetes thyroid disease high blood pressure difficulty in urination due to enlargement of the prostate gland When using this product do not exceed recommended dosage. Stop use and ask a doctor if nervousness, dizziness, or sleeplessness occur symptoms do not improve within 7 days or occur with fever If pregnant or breast-feeding, as a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.